Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat

NCT00525044 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharyngitis

Interventions

DRUG: Ambroxol
DRUG: Placebo

Sponsor

Boehringer Ingelheim